Juvederm Voluma Fills Unique Facial Niche

Reviewed by Julius Few, MD

Juvederm Voluma is the only hyaluronic-acid based dermal filler approved by the U.S. Food and Drug Administration for volume loss in the cheeks or midface.

Juvederm Voluma is already approved in 65 countries, including Canada, parts of Europe and South America. It is slated to be available in the US as early as Fall 2013.

Juvederm Voluma vs. Other Fillers

Do we really need another filler? Yes, we do, experts say. Other hyaluronic-acid fillers are great for fine lines and wrinkles around the mouth, nose and eyes, but Juvederm Voluma is for larger areas that need more fill.

Fat injections are often used to treat the same areas as Voluma. One of the issues with fat injections, however, is that results are not always predictable. The fat must also be grafted or taken from another part of the body where it is more plentiful. This means it is a two-step procedure. Out-of-the-box injectables such as Juvederm Voluma require just one step.

Results of surveys from studies involving Juvederm Voluma suggest that nearly all participants would recommend treatment to a friend, and most would come back for more themselves. Voluma injections contain lidocaine to reduce the pain associated with the shots. Side effects may include redness, swelling, or bruising after treatment. Voluma is less likely to cause nodules and granulomas (bumps and lumps) and or/migrate than other fillers on the market including Sculptra and Radiesse. There is no downtime, and results are immediate and last up to 18 months. Cost information is not yet avialable.

If you are interested in facial rejuvenation procedures, schedule a consultation with a board-certified plastic surgeon to find out what options are currently available that can help you achieve your cosmetic goals. Start your search here.

About the Reviewer of This Article

Julius Few, MD, is the founder of the Few Institute For Aesthetic Plastic Surgery in Chicago. Board certified by the American Board of Plastic Surgery and the American Board of Surgery, he is also a clinical associate professor in the division of plastic surgery at the University of Chicago and the current president of the Illinois Society of Plastic Surgeons.

Dr. Few received his medical degree from the University of Chicago Pritzker School of Medicine, and completed his residency in general surgery at the University of Michigan Medical Center in Ann Arbor, followed by plastic surgery training at Northwestern University in Chicago. He has also received special facial and eye cosmetic training in Honolulu, New York and Atlanta.